Robert W. Baird Lowers Mettler-Toledo International (NYSE:MTD) Price Target to $1,310.00

Mettler-Toledo International (NYSE:MTD - Free Report) had its price objective lowered by Robert W. Baird from $1,375.00 to $1,310.00 in a research note issued to investors on Monday morning,Benzinga reports. The firm currently has a neutral rating on the medical instruments supplier's stock.

A number of other brokerages have also commented on MTD. Stifel Nicolaus increased their price target on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a "buy" rating in a report on Monday, August 5th. Wells Fargo & Company assumed coverage on Mettler-Toledo International in a report on Tuesday, August 27th. They issued an "equal weight" rating and a $1,400.00 price objective for the company. Evercore ISI raised their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. upped their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a research note on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $1,338.75.

Mettler-Toledo International Trading Down 5.5 %

Shares of Mettler-Toledo International stock traded down $71.76 during trading on Monday, hitting $1,238.27. The stock had a trading volume of 173,721 shares, compared to its average volume of 133,540. Mettler-Toledo International has a 12 month low of $1,015.29 and a 12 month high of $1,546.93. The firm has a market cap of $26.27 billion, a price-to-earnings ratio of 34.44, a P/E/G ratio of 3.83 and a beta of 1.16. The business's 50-day moving average is $1,398.01 and its 200 day moving average is $1,402.52.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts' consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. As a group, equities analysts expect that Mettler-Toledo International will post 40.34 EPS for the current year.

Insider Activity

In related news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.94% of the company's stock.

Institutional Trading of Mettler-Toledo International

A number of large investors have recently made changes to their positions in MTD. Capital International Investors grew its stake in shares of Mettler-Toledo International by 15.1% during the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier's stock valued at $1,431,696,000 after purchasing an additional 141,431 shares during the period. PineStone Asset Management Inc. increased its holdings in Mettler-Toledo International by 127.4% during the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier's stock valued at $362,855,000 after buying an additional 145,453 shares during the last quarter. TD Asset Management Inc raised its position in Mettler-Toledo International by 1.9% in the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier's stock worth $219,767,000 after acquiring an additional 2,866 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Mettler-Toledo International by 32.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier's stock worth $199,777,000 after acquiring an additional 35,048 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Mettler-Toledo International by 88.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier's stock valued at $163,290,000 after acquiring an additional 57,509 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.